We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Astex Pharmaceuticals to Present AT26893 at EASL

News   Apr 16, 2012

 
Astex Pharmaceuticals to Present AT26893 at EASL
 
 
 

RELATED ARTICLES

$3M Grant to Advance Drugs for ALS, Alzheimer's & Parkinson's

News

A new four-year, $3 million grant will enable Scripps Research scientists to advance compounds that may protect neurons in diseases caused by toxic protein accumulation, including Parkinson’s, ALS, Alzheimer’s and Creutzfeldt-Jakob disease.

READ MORE

A Way to Enhance Adsorption of Chemotherapy Drugs

News

A new study demonstrates adsorption of chemotherapy drugs onto active carbon delivery capsule can be enhanced with aluminium atom inclusions.

READ MORE

Gout Get Outta Here

News

Researchers found a significant reduction in risk of gout attacks among patients who received the drug (canakinumab) that targets a key inflammatory molecule, suggesting a new target for therapeutic strategies to prevent gout attacks.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE